会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 46. 发明授权
    • Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
    • 用于预防呼肠孤病毒识别用于治疗细胞增殖性疾病的方法
    • US06565831B1
    • 2003-05-20
    • US09636597
    • 2000-08-10
    • Matthew C. CoffeyBradley G. Thompson
    • Matthew C. CoffeyBradley G. Thompson
    • A61K4800
    • A61K35/765A61K38/13C07K16/081C07K16/10C07K16/4216C12N9/1205C12N2720/12232Y10S435/948Y10S435/975A61K2300/00
    • The present invention pertains to methods for preventing reovirus recognition in the treatment of cellular proliferative disorders, and particularly ras-mediated cellular proliferative disorders, in mammals. The method comprises suppressing or otherwise inhibiting the immune system of the mammal and, concurrently or subsequently, administering to the proliferating cells an effective amount of one or more reoviruses under conditions which result in substantial lysis of the proliferating cells. The methods may include the selective removal of immune constituents that may interfere with the systemic delivery of the virus; preventing reovirus recognition by the host immune system; and removal of the virus from an immune suppressed or immune incompetent host following treatment with reovirus. Alternatively, reovirus may be administered to a mammal with a diminished immune response system under conditions which result in substantial lysis of the proliferating cells.
    • 本发明涉及在哺乳动物中治疗细胞增殖性疾病,特别是ras介导的细胞增殖性疾病中预防呼肠孤病毒识别的方法。 该方法包括抑制或以其他方式抑制哺乳动物的免疫系统,并且同时或随后在导致增殖细胞的实质性裂解的条件下向增殖细胞施用有效量的一种或多种呼吸道病毒。 所述方法可以包括选择性去除可能干扰病毒的全身递送的免疫组分; 预防宿主免疫系统的呼肠孤病毒识别; 并在用呼肠孤病毒治疗后从免疫抑制或免疫不称职的宿主中除去病毒。 或者,呼肠孤病毒可以在导致增殖细胞的实质性裂解的条件下给予具有减少的免疫应答系统的哺乳动物。
    • 49. 发明授权
    • Reovirus for the treatment of cellular proliferative disorders
    • 用于治疗细胞增殖性疾病的呼肠孤病毒
    • US08066985B2
    • 2011-11-29
    • US12323223
    • 2008-11-25
    • Patrick W. K. LeeJames StrongMatthew C. Coffey
    • Patrick W. K. LeeJames StrongMatthew C. Coffey
    • A61K49/00A61K39/15
    • A61K9/0019A61K35/765C12N2720/12032C12N2720/12232
    • Methods for treating proliferative disorders, by administering reovirus to a Ras-mediated proliferative disorder, are disclosed. The reovirus is administered so that it ultimately directly contacts ras-mediated proliferating cells. Proliferative disorders include but are not limited to neoplasms. Human reovirus, non-human mammalian reovirus, and/or avian reovirus can be used. If the reovirus is human reovirus, serotype 1 (e.g., strain Lang), serotype 2 (e.g., strain Jones), serotype 3 (e.g., strain Dearing or strain Abney), as well as other serotypes or strains of reovirus can be used. Combinations of more than one type and/or strain of reovirus can be used, as can reovirus from different species of animal. Either solid neoplasms or hematopoietic neoplasms can be treated.
    • 公开了通过向Ras介导的增殖性病症施用呼肠孤病毒来治疗增殖性疾病的方法。 施用呼肠孤病毒使其最终直接接触ras介导的增殖细胞。 增生性疾病包括但不限于赘生物。 可以使用人呼肠病毒,非人哺乳动物呼肠病毒和/或禽呼肠孤病毒。 如果呼肠孤病毒是人呼肠病毒,则可以使用血清型1(例如,菌株Lang),血清型2(例如菌株琼斯),血清型3(例如,菌株Dearing或菌株Abney)以及呼肠孤病毒的其它血清型或菌株。 可以使用多于一种类型和/或菌株的呼肠病病毒的组合,以及来自不同动物种类的呼肠弧病毒。 可以治疗实体肿瘤或造血赘生物。
    • 50. 发明授权
    • Reovirus for the treatment of neoplasia
    • 呼肠孤病毒治疗瘤形成
    • US06576234B2
    • 2003-06-10
    • US09852017
    • 2001-05-10
    • Patrick W. K. LeeJames StrongMatthew C. Coffey
    • Patrick W. K. LeeJames StrongMatthew C. Coffey
    • A01N6300
    • C12N9/1205A61K35/765C12N7/00C12N2720/12232C12N2720/12261
    • Methods for treating neoplasia, by administering reovirus to a Ras-mediated neoplasm, and use of reovirus for manufacture of a medicament for the treatment of neoplasia, are disclosed. The reovirus is administered so that it ultimately directly contacts cells of the neoplasm. Human reovirus, non-human mammalian reovirus, and/or avian reovirus can be used. If the reovirus is human reovirus, type 1 (e.g., strain Lang), type 2 (e.g., strain Jones), type 3 (e.g., strain Dearing or strain Abney), as well as other sterotypes or strains of reovirus can be used. Combinations of more than one type and/or strain or reovirus can be used, as can reovirus from different species of animal. Either solid neoplasms or hematopoietic neoplasms can be treated.
    • 公开了通过向Ras介导的肿瘤施用呼肠孤病毒和使用呼肠孤病毒来制造用于治疗肿瘤的药物的方法。 呼肠病毒的施用使其最终直接接触肿瘤细胞。 可以使用人呼肠病毒,非人哺乳动物呼肠病毒和/或禽呼肠孤病毒。 如果呼肠孤病毒是人呼肠病毒,可以使用1型(例如,菌株Lang),2型(例如菌株琼斯),3型(例如,菌株Dearing或菌株Abney)以及其它定向型或呼肠孤病毒菌株。 可以使用多于一种类型和/或菌株或呼肠孤病毒的组合,以及来自不同动物种的呼肠病毒。 可以治疗实体肿瘤或造血赘生物。